C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 38/16 (2006.01) C07K 14/705 (2006.01) C07K 19/00 (2006.01)
Patent
CA 2690056
The present invention provides novel therapeutics and methods of treatment for diseases associated with activation of the advanced glycatio.pi. endproducts receptor (RAGE).
L'invention concerne de nouvelles thérapies et procédés de traitement pour des maladies associées à l'activation du récepteur de produits finaux de glycation avancée (RAGE).
Bleck Gregory T.
Hilbert David M.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Galactica Pharmaceuticals Inc.
LandOfFree
Rage fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rage fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rage fusion proteins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1996720